Neuroendocrine Skin Carcinoma Coexpressing Cytokeratin and Neurofilament Proteins

Tang CK, 1978, Cancer, 42, 2311, 10.1002/1097-0142(197811)42:5<2311::AID-CNCR2820420531>3.0.CO;2-L

Gould VE, 1979, Surg Clin North Am, 59, 93, 10.1016/S0039-6109(16)41736-6

Johannessen JV, 1980, Hum Pathol, 11, 586

Gould VE, 1980, Ultrastruct Pathol, 1, 499, 10.3109/01913128009140557

10.1097/00000478-198006000-00001

Sidhu GS, 1980, Am J Dermatopathol, 2, 101, 10.1097/00000372-198000220-00001

Silva E, 1981, Ultrastruct Pathol, 2, 1, 10.3109/01913128109031497

Gloor F, 1980, Schweiz med Wochensch, 112, 141

Gould VE, Evolution and tumor pathology of the neuroendocrine system, 545

Miettinen M, 1983, Ultrastruct Pathol, 4, 219, 10.3109/01913128309140792

Green WR, Linnoila RI, Triche TJ. Neuroendocrine carcinoma of skin with simultaneous cytokeratin expression. Ultrastruct Pathol. 1984; 141–152

Hoefler H, 1984, Am J Dermatopathol, 6, 525, 10.1097/00000372-198412000-00002

Gould VE, 1985, Lab Invest, 52, 334

Schmechel DE, 1985, Lab Invest, 52, 239

Haimoto H, 1985, Lab Invest, 52, 257

Nesland JM, 1985, Ultrastruct Pathol, 8, 225, 10.3109/01913128509142155

Gabbiani G, 1981, Am J Pathol, 104, 206

Osborn M, 1983, Lab Invest, 48, 372

Le Douarin N. The neural crest. Cambridge University Press, Cambridge, UK 1982; 54–133

Blobel G, 1985, Lab Invest, 52, 39

Miettinen M, 1985, Lab Invest, 52, 429

Blobel Ga Moll R, Am J Pathol

Memoli VA, 1985, Ultrastruct Pathol, 7, 268

Gould VE, The intermediate filament complement of the spectrum of nerve sheath neoplasms